Indaptus Therapeutics expands patent portfolio in China, Japan, Israel
Indaptus Therapeutics (INDP) has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use ...
Investing8d
Indaptus secures new patents in Asia and Israel for Decoy platform
The patents are for the use of Decoy bacteria compositions in the prevention and treatment of Hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Dr. Michael Newman, the company’s ...